Kathy J. Warden
Chair, CEO and President at Northrop Grumman Corporation
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Northrop Grumman Corporation, 3 years.
Chief executive roles
Solid · grade C
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 50% of the scoring weight is on file.
- Dividends 15%
- 84
- Revenue growth 20%
- 61
- Earnings growth 15%
- 67
dividend grew 9.7% a year
4.9% a year in revenue
6.7% a year in earnings per share
50% of the scoring weight is on file. Figures cover December 2018 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Merck & Company Inc. May 26, 202698.2%
-
Merck & Company Inc. May 27, 202597.3%
-
Merck & Company Inc. May 23, 202397.8%
-
Northrop Grumman Corporation May 17, 202396.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 17, 2026 | Northrop Grumman Corporation | Option exercise | +10,760 | — | — |
| Feb 17, 2026 | Northrop Grumman Corporation | Shares withheld for tax | −4,857 | $701.12 | $3,405,340 |
| Feb 11, 2026 | Northrop Grumman Corporation | Option exercise | +34,546 | — | — |
| Feb 11, 2026 | Northrop Grumman Corporation | Shares withheld for tax | −15,371 | $678.83 | $10,434,296 |
| Feb 6, 2026 | Northrop Grumman Corporation | Open-market sale | −214 | $705.84 | $151,050 |
| Feb 6, 2026 | Northrop Grumman Corporation | Open-market sale | −2,196 | $706.65 | $1,551,803 |
| Feb 6, 2026 | Northrop Grumman Corporation | Open-market sale | −4,695 | $707.45 | $3,321,478 |
| Feb 6, 2026 | Northrop Grumman Corporation | Open-market sale | −2,303 | $708.63 | $1,631,975 |
| Feb 6, 2026 | Northrop Grumman Corporation | Open-market sale | −5,734 | $709.49 | $4,068,216 |
| Feb 6, 2026 | Northrop Grumman Corporation | Open-market sale | −3,552 | $710.36 | $2,523,199 |
| Feb 6, 2026 | Northrop Grumman Corporation | Open-market sale | −1,306 | $711.14 | $928,749 |
| Jan 6, 2026 | Northrop Grumman Corporation | Open-market sale | −3,000 | $615.00 | $1,845,000 |
| Jan 5, 2026 | Northrop Grumman Corporation | Open-market sale | −7,000 | $600.00 | $4,200,000 |
| Jun 13, 2025 | Northrop Grumman Corporation | Open-market sale | −7,500 | $505.77 | $3,793,275 |
| Jun 12, 2025 | Northrop Grumman Corporation | Open-market sale | −3,750 | $495.00 | $1,856,250 |
Questions about Kathy J. Warden
What boards is Kathy J. Warden on?
Kathy J. Warden sits on the boards of Merck & Company Inc. and Northrop Grumman Corporation.
What company is Kathy J. Warden the CEO of?
Kathy J. Warden has been Chair, CEO and President of Northrop Grumman Corporation since January 2019.
How long has Kathy J. Warden served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.